Nab-Xelpac – 100 mg/vial IV Infusion

22,622.50৳ 

Dosage : IV Infusion
Strength : 100 mg/vial
Generic : Nab-Paclitaxel [Nanoparticle Albumin-Bound Paclitaxel]
Pack Size : 1 Pack = NA
Manufacturer : Beacon Pharmaceuticals Ltd.

+
  • Nab-Xelpac - 100 mg/vial IV Infusion

    22,622.50৳ 

    Request a Call Back

    •  Size Guide

      Size Guide

    •  Delivery & Return

      Delivery

      Delivery Type

      Delivery Charge

      Delivery Time

      Free Delivery

      Free

      01 – 48 Hours

      Regular Delivery

      Tk. 25

      01 – 48 Hours

      Express Delivery

      Tk. 80

      01 – 03 Hours

      Store Pickup

      Free

      Currently, we deliver within 01 KM radius, Except as per the discussion

      Returns

      Return  FREE

      You can easily return your ordered medicine if :

      • Product Damaged
      • Expired
      • or Wrong Medicine

      found above issue please return to our delivery personnel during delivery time. After that we are unable to return your medicine.

    •  Ask a Question

      Nab-Xelpac - 100 mg/vial IV Infusion

      22,622.50৳ 

      Ask a Question

        ... people are viewing this right now

        Share
      Guaranteed Safe CheckoutTrust
      Metastatic Breast Cancer: After failure of combination chemotherapy for metastatic breast cancer or relapse within 6 months of?adjuvant?chemotherapy, the recommended regimen for Nab-Paclitaxel is 260 mg/m? administered intravenously over 30 minutes every 3 weeks.

      Non-Small Cell Lung Cancer: The recommended dose of Nab-Paclitaxel is 100 mg/m? administered as an intravenous infusion over 30 minutes on Days 1, 8, and 15 of each 21-day cycle. Administer carboplatin on Day 1 of each 21 day cycle immediately after Nab-Paclitaxel.

      Adenocarcinoma Of The Pancreas: The recommended dose of Nab-Paclitaxel is 125 mg/m? administered as an intravenous infusion over 30-40 minutes on Days 1, 8 and 15 of each 28-day cycle. Administer gemcitabine immediately after Nab-Paclitaxel on Days 1, 8 and 15 of each 28-day cycle.

      Dosage In Patients With Hepatic Impairment: For patients with mild hepatic impairment (total bilirubin greater than ULN and less than or equal to 1.5 x ULN and?aspartate aminotransferase?[AST] less than or equal to 10 x ULN), no dose adjustments are required, regardless of indication.

      Do not administer Nab-Paclitaxel to patients with metastatic adenocarcinoma of the pancreas who have moderate to severe hepatic impairment. Do not administer Nab-Paclitaxel to patients with total bilirubin greater than 5 x ULN or AST greater than 10 x ULN regardless of indication as these patients have not been studied.

      Based on 0 reviews

      0.00 Overall
      0%
      0%
      0%
      0%
      0%
      Be the first to review “Nab-Xelpac – 100 mg/vial IV Infusion”

      Your email address will not be published. Required fields are marked *

      Write a review

      Reviews

      There are no reviews yet.

      My Cart
      Close Wishlist
      Close Recently Viewed
      Categories